Dihydroberberine: Research, Dosing, and Where to Buy in 2026
A research-first profile for Dihydroberberine (DHB), aggregating mechanism notes, transcript dosing mentions, vendor recommendations, and PubMed-indexed literature without presenting medical guidance.
Dihydroberberine is a research compound profiled here from named-expert transcripts and peer-reviewed literature, without medical guidance. As of July 2026, The Peptide Wiki aggregates 8 PubMed-cited papers, and 1 transcript dosing protocol for Dihydroberberine, each linked to its source.
- Also indexed as DHB.
- 1 aggregated dosing-protocol mention from source transcripts.
- 8 PubMed-indexed citations listed in the research table below.
- 0 vendor recommendations captured from named experts.
What is Dihydroberberine?
Research compound aggregated from creator and literature mentions. No direct disease-treatment claims are made on this page.
Dihydroberberine Dosing Protocols
The entries below are transcript-derived dosing mentions. They are preserved for research context and are not medical advice.
| Speaker | Source | Timestamp | Protocol | Evidence |
|---|---|---|---|---|
| Scott | New Information on the HGH Crackdown + PED Q&A | 00:21:42 | Example discussed: 200 mg dihydroberberine tablet three times daily versus 500 mg traditional berberine tablet three times daily. | anecdotal |
Where to Buy Dihydroberberine in 2026
No tracked vendor recommendations for Dihydroberberine yet. See our vendor directory.
Side Effects and Safety
Anecdotal reports and study-level observations vary by route, dose, and individual. This page does not provide medical advice. Consult a qualified clinician before any research use.
User Reviews
User reviews aggregator coming Q3 2026 (Reddit + YouTube comments + Discord research notes). Until then, see the expert quote section above and PubMed citations below.
Research Efficacy Snapshot
Published efficacy percentages cited in PubMed trials and named-expert reports about Dihydroberberine. Each line links to the original source.
- "TMA and TMAO in patients decreased by 38 and 29% in faeces (*P < 0.05; *P < 0.05), and 37 and 35% in plasma (***P < 0.001; *P < 0.05), after 4 months on BBR." · Ma S et al, 2022 PubMed
- "Acute colitis model was established by gavage with 3% dextran sulfate sodium (DSS) for 8 days." · Li C et al, 2021 PubMed
Research and Studies
8 PubMed-indexed papers reference Dihydroberberine. Top 8 shown.
Legal Status
Dihydroberberine is presented here as a research compound. FDA approval status, scheduling, WADA status, and state-specific telehealth rules may apply. Always verify current regulatory status. Last verified: 2026-07-09.
Frequently Asked Questions
Is Dihydroberberine FDA-approved?
Dihydroberberine is presented on this page as a research compound. FDA approval status, scheduling, and state-specific rules may apply and change. Verify current regulatory status before any decision.
What dosing is reported for Dihydroberberine?
This page aggregates 1 dosing-protocol mention(s) from named-expert transcripts, each linked to a verbatim source timestamp. See the Dosing Protocols table above. Mentions are anecdotal, not medical advice.
How much research has been published on Dihydroberberine?
8 PubMed-indexed paper(s) reference Dihydroberberine in our current research feed. See the Research and Studies section above for citations.